// App-Quantinova.ai

: Comparison of Unfractionated Heparin and Bivalirudin for Treatment of Suspected Device Thrombosis during Heart Mate II Support

Researchers

Presenter

  • K. Shah

Principal Investigators

  • D.B. Sims

  • S. Forest

  • T. Chinnadurai

  • Y. Xia

  • A. Luke

  • D. Nnani

  • C. Castillo

  • M. Taveras

  • S. Vukelic

  • S.R. Patel

  • J. Shin

  • D.J. Goldstein

  • U.P. Jorde

  • O. Saeed

Medical Centers

  • Orthopaedic Surgery, Montefiore Medical Center, Bronx, NY

  • Medicine (Cardiology), Montefiore Medical Center, Bronx, NY

  • Montefiore Medical Center, Bronx, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Heparin

  • Bivalirudin

  • Heparin

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A